Crinetics Pharmaceuticals, Inc. Deferred Tax Liabilities, Gross
Crinetics Pharmaceuticals, Inc. (CRNX) had Deferred Tax Liabilities, Gross of $9.24 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-02-26
- 2025-12-31: Deferred Tax Liabilities, Gross $9.24M.
- 2024-12-31: Deferred Tax Liabilities, Gross $9.75M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $9.24M 10-K · filed 2026-02-26 |
| 2024-12-31 | $9.75M 10-K · filed 2026-02-26 |